Sage Therapeutics CEO cashes in $35M worth of stock options

Jeff Jonas, the CEO of a Cambridge developer of drugs to treat depression, got a holiday gift of more than $35 million last week after exercising stock options and then selling most of the resulting shares at record-high prices.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.